DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

PEG-Intron (Peginterferon Alfa-2B) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (63)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) disability. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 63   Next >>

Possible PEG-Intron side effects in

Reported by a individual with unspecified qualification from United States on 2012-08-23

Patient:

Reactions: Anal Fistula, Anorectal Discomfort, Haemorrhoids, Anaemia, Adverse Event

Adverse event resulted in: disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 microgram, qw
    Start date: 2012-05-25

Ribasphere
    Dosage: 200mg in am 400mg pm

Other drugs received by patient: Procrit; Telaprevir



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Cheilitis, Rash

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Telavic
    Dosage: 2250 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-29
    End date: 2012-05-31

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-29

Telavic
    Administration route: Oral
    Start date: 2012-06-01

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-29

Other drugs received by patient: Urso 250



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Anti-Neutrophil Cytoplasmic Antibody Positive Vasculitis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: daily dosage unknown
    Indication: Hepatitis C
    Start date: 2010-01-01

Rebetol
    Dosage: daily dosage unknown
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-01-01



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Haemoglobin Decreased, Anaemia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Start date: 2012-06-05
    End date: 2012-06-25

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-05
    End date: 2012-07-10

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-05
    End date: 2012-07-10

PEG-Intron
    Dosage: 1.5mcg/kg
    Indication: Hepatitis C
    Start date: 2012-06-05
    End date: 2012-07-10

PEG-Intron
    Dosage: 50mcg/week
    Start date: 2012-06-26
    End date: 2012-07-09

Other drugs received by patient: Miglitol; Metformin HCL



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient:

Reactions: Viral Load Increased, Vomiting, Contusion, Paranoia, Hyperhidrosis, Polyneuropathy, Joint Stiffness, Hallucination, Visual, Diarrhoea, Treatment Failure, Infection

Adverse event resulted in: disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Start date: 2008-01-01
    End date: 2008-07-01

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2006-12-01
    End date: 2007-08-01

PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2006-12-01
    End date: 2007-08-01

Rebetol
    Dosage: unk
    Start date: 2008-01-01
    End date: 2008-07-01



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient:

Reactions: Myalgia, Bedridden, Vomiting, Fatigue, Nausea, Photophobia, Headache, Muscle Spasms

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Victrelis
    Indication: Hepatitis C

PEG-Intron

Ribasphere



Possible PEG-Intron side effects in male

Reported by a individual with unspecified qualification from France on 2012-08-09

Patient: male, weighing 61.0 kg (134.2 pounds)

Reactions: Tooth Disorder

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

PEG-Intron
    Dosage: 30 ?g, qw
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Peginterferon Alfa-2B
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Peginterferon Alfa-2B
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Placebo
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Ribavirin
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Ribavirin
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Placebo
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-09

Patient:

Reactions: Bowel Movement Irregularity, Tinnitus, Feeling Hot, Anaemia, Loss of Consciousness

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-07-22

PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-07-22

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-08-20



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-09

Patient:

Reactions: Bowel Movement Irregularity, Tinnitus, Feeling Hot, Anaemia, Loss of Consciousness

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-08-20

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-07-22

PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-07-22



Possible PEG-Intron side effects in male

Reported by a individual with unspecified qualification from France on 2012-08-09

Patient: male, weighing 61.0 kg (134.2 pounds)

Reactions: Tooth Disorder

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Placebo
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Peginterferon Alfa-2B
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Peginterferon Alfa-2B
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Ribavirin
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

PEG-Intron
    Dosage: 30 ?g, qw
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Ribavirin
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Placebo
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-07

Patient:

Reactions: Procedural Pain, Back Pain, Hepatic Pain, Arthralgia, Panic Reaction, Influenza Like Illness

Adverse event resulted in: disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-29

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-29



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01

Patient:

Reactions: Dyspnoea, Anaemia, Rash, Headache, Generalised Oedema, Anxiety, Gastrointestinal Pain, Fatigue, Diarrhoea, Visual Impairment, Depression, Mood Swings, Cough, Decreased Appetite

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Ribasphere
    Dosage: unk
    Start date: 2012-04-27
    End date: 2012-07-16

PEG-Intron
    Dosage: 150 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-04-27
    End date: 2012-07-16

Telaprevir
    Dosage: unk



Possible PEG-Intron side effects in

Reported by a individual with unspecified qualification from France on 2012-07-26

Patient:

Reactions: Tooth Disorder

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 30 ?g, qw
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Placebo
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Ribavirin
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Peginterferon Alfa-2B
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-07-23

Patient:

Reactions: Encephalopathy, Ascites

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Victrelis
    Dosage: 200 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-02
    End date: 2012-06-08

Rebetol
    Indication: Hepatitis C

PEG-Intron
    Indication: Hepatitis C



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-19

Patient:

Reactions: Bowel Movement Irregularity, Tinnitus, Anaemia, Feeling Hot, Loss of Consciousness

Adverse event resulted in: death, hospitalization, disablity

Drug(s) suspected as cause:
Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-08-20

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-07-22

PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-07-22



Possible PEG-Intron side effects in

Reported by a physician from Bulgaria on 2012-07-19

Patient:

Reactions: Macular Oedema, Blindness, Papilloedema

Adverse event resulted in: disablity

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C

Rebetol
    Administration route: Oral
    Indication: Hepatitis C



Possible PEG-Intron side effects in 61 year old male

Reported by a physician from United States on 2012-06-13

Patient: 61 year old male

Reactions: Gastrointestinal Motility Disorder, Pain, Impaired Work Ability, Emotional Disorder, Haemoglobin Increased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Ribavirin
    Dosage: bid
    Indication: Hepatitis C
    Start date: 2012-05-01

PEG-Intron
    Dosage: qw
    Indication: Hepatitis C
    Start date: 2012-05-01

Other drugs received by patient: Vitamins E; Vitamins C



Possible PEG-Intron side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-12

Patient: 50 year old male

Reactions: Haemoglobin Decreased, Dyspnoea, Arthralgia, Abdominal Distension

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Ribavirin
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: ; po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-01

PEG-Intron
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Megace; Zoloft



Possible PEG-Intron side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-12

Patient: male

Reactions: Weight Decreased, Pruritus, Substance Use, Hunger, Abnormal Dreams, Back Pain, Polydipsia, Pain in Extremity, Eye Inflammation, Foreign Body Sensation in Eyes, Application Site Pain, Insomnia, Rash Erythematous, Pancreatitis, Injection Site Discolouration, Chills, Pain, Poor Quality Sleep, Myalgia, Fatigue, Liver Function Test Abnormal, Anger, Blood Glucose Increased, Decreased Appetite, Vomiting, Nausea, Musculoskeletal Chest Pain, Application Site Rash, Dysgeusia, Burning Sensation, Pollakiuria, Asthenia, Feeling Abnormal, Influenza

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Ribavirin
    Indication: Hepatitis C
    Start date: 2012-04-06

PEG-Intron
    Indication: Hepatitis C
    Start date: 2012-04-06



Possible PEG-Intron side effects in 68 year old male

Reported by a physician from Japan on 2012-06-11

Patient: 68 year old male, weighing 61.0 kg (134.2 pounds)

Reactions: Blood Bilirubin Increased, Contusion, Pruritus, Ear Haemorrhage, Anaemia, Laceration, Rash, Fall, Subdural Haematoma, Skull Fractured Base, Hearing Impaired, Blood Creatinine Increased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 mcg/kg, qw, sc
    Indication: Hepatitis C
    Start date: 2012-02-02

Rebetol
    Dosage: 800;600;400;200 mg, qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-06
    End date: 2012-04-19

Rebetol
    Dosage: 800;600;400;200 mg, qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-20

Rebetol
    Dosage: 800;600;400;200 mg, qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-02-29

Rebetol
    Dosage: 800;600;400;200 mg, qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-01
    End date: 2012-04-05

Telavic (Antivirals Nos)
    Dosage: 2250;1500 mg, qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-04-26

Telavic (Antivirals Nos)
    Dosage: 2250;1500 mg, qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-04-12

Other drugs received by patient: Voltaren; Actos; Glyburide; Epadel-S; Actos



Possible PEG-Intron side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-08

Patient: male

Reactions: Tinnitus, Faecal Incontinence, Loss of Consciousness

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Ribavirin
    Indication: Hepatitis C
    Start date: 2011-07-22

PEG-Intron
    Indication: Hepatitis C
    Start date: 2011-07-22

Victrelis
    Indication: Hepatitis C
    Start date: 2011-08-20



Possible PEG-Intron side effects in 54 year old female

Reported by a pharmacist from United States on 2012-06-04

Patient: 54 year old female

Reactions: Drug Dose Omission, Spinal Pain, Pain in Extremity, Drug Ineffective, Chest Pain, Muscle Spasms, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
PEG-Intron

Other drugs received by patient: Dilaudid



Possible PEG-Intron side effects in 55 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-31

Patient: 55 year old female

Reactions: Intention Tremor, Motor Dysfunction

Adverse event resulted in: disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: qw
    Indication: Hepatitis C
    End date: 2011-12-01

Ribavirin
    Indication: Product Used FOR Unknown Indication



Possible PEG-Intron side effects in 59 year old female

Reported by a physician from Japan on 2012-05-30

Patient: 59 year old female, weighing 79.0 kg (173.8 pounds)

Reactions: Subarachnoid Haemorrhage, Platelet Count Decreased, Intracranial Aneurysm, Hypoaesthesia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 mcg;qw;sc, 100 mcg;qw;sc, 80 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2010-12-17
    End date: 2011-01-14

PEG-Intron
    Dosage: 120 mcg;qw;sc, 100 mcg;qw;sc, 80 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2011-01-21
    End date: 2011-01-27

PEG-Intron
    Dosage: 120 mcg;qw;sc, 100 mcg;qw;sc, 80 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2010-11-05
    End date: 2010-12-10

Rebetol
    Dosage: 400 mg;bid;po, 200 mg;bid;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-11-05
    End date: 2011-02-03

Rebetol
    Dosage: 400 mg;bid;po, 200 mg;bid;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-02-04
    End date: 2012-01-28

Other drugs received by patient: Amlodipine / 00972402 /; Miglitol; Juzentaihoto



Possible PEG-Intron side effects in 68 year old male

Reported by a physician from Japan on 2012-05-25

Patient: 68 year old male, weighing 61.0 kg (134.2 pounds)

Reactions: Blood Bilirubin Increased, Contusion, Ear Haemorrhage, Anaemia, Fall, Ear Canal Injury, Skull Fractured Base, Hearing Impaired

Adverse event resulted in: disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 mcg/kg, qw, sc
    Indication: Hepatitis C
    Start date: 2012-02-02

Rebetol
    Dosage: 800;600 mg, qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-01

Rebetol
    Dosage: 800;600 mg, qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-02-29

Other drugs received by patient: Glyburide; Actos; Epadel-S; Voltaren



Possible PEG-Intron side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-14

Patient: male

Reactions: Injection Site Discolouration, Weight Decreased, Pain, Chills, Substance Abuse, Hunger, Abdominal Pain Upper, Abnormal Dreams, Myalgia, Fatigue, Liver Function Test Abnormal, Anger, Decreased Appetite, Polydipsia, Back Pain, Vomiting, Pain in Extremity, Nausea, Eye Inflammation, Musculoskeletal Chest Pain, Dysgeusia, Burning Sensation, Rash Erythematous, Pollakiuria, Pancreatitis, Asthenia, Feeling Abnormal, Mobility Decreased, Influenza

Adverse event resulted in: disablity

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C
    Start date: 2012-04-06

Ribavirin
    Indication: Hepatitis C
    Start date: 2012-04-06

Telaprevir
    Indication: Hepatitis C
    Start date: 2012-04-06



Possible PEG-Intron side effects in 68 year old male

Reported by a physician from Japan on 2012-04-16

Patient: 68 year old male, weighing 61.0 kg (134.2 pounds)

Reactions: Haemoglobin Decreased, Contusion, Ear Haemorrhage, Hearing Impaired, Skull Fractured Base, Fall

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Telavic (Antivirals Nos)
    Dosage: 2250 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-02

Rebetol
    Dosage: 800 mg;qd;po 600 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-01

Rebetol
    Dosage: 800 mg;qd;po 600 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-02-29

PEG-Intron
    Dosage: 1.5 mcg/kg;qw;sc
    Indication: Hepatitis C

Other drugs received by patient: Actos; Glyburide; Voltaren; Epadel-S



Possible PEG-Intron side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-05

Patient: 57 year old female

Reactions: Pneumonia, Staphylococcal Infection, Lung Infection, Escherichia Infection, Candidiasis

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Ribavirin
    Dosage: qd, po
    Administration route: Oral
    Indication: Hepatitis C

PEG-Intron
    Dosage: qw
    Indication: Hepatitis C
    Start date: 2011-07-01

Victrelis
    Dosage: qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-01

Victrelis
    Dosage: qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-08-01
    End date: 2012-01-01



Possible PEG-Intron side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-02

Patient: 57 year old female

Reactions: Pneumonia, Staphylococcal Infection, Escherichia Infection, Candidiasis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Victrelis
    Dosage: ;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-01

Victrelis
    Dosage: ;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-08-01
    End date: 2012-01-01

Ribavirin
    Dosage: ;qd;po
    Administration route: Oral
    Indication: Hepatitis C

PEG-Intron
    Dosage: ;qw;
    Indication: Hepatitis C
    Start date: 2011-07-01



Possible PEG-Intron side effects in 26 year old male

Reported by a pharmacist from United States on 2012-03-21

Patient: 26 year old male

Reactions: Anaemia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
PEG-Intron

Ribavirin
    Dosage: 4 df, qd
    Indication: Product Used FOR Unknown Indication

PEG-Intron
    Dosage: 120 mcg, qw,sc
    Indication: Hepatitis C
    Start date: 2010-06-28



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012